高等学校化学学报
高等學校化學學報
고등학교화학학보
Chemical Journal of Chinese Universities
2015年
9期
1687-1693
,共7页
黄丽君%张丽华%毛红菊%王萍%蒋友旭%李盼盼%金庆辉%赵建龙
黃麗君%張麗華%毛紅菊%王萍%蔣友旭%李盼盼%金慶輝%趙建龍
황려군%장려화%모홍국%왕평%장우욱%리반반%금경휘%조건룡
纳米金探针%蛋白芯片%杂交%心肌损伤标志物
納米金探針%蛋白芯片%雜交%心肌損傷標誌物
납미금탐침%단백심편%잡교%심기손상표지물
Gold nanoparticles probe%Protein chip%Hybridization%Myocardial injury marker
运用纳米金复合探针结合蛋白芯片,建立了一种检测心肌损伤标志物的新方法。构建了2种纳米金探针:标记有检测抗体和DNA探针1的检测探针和标记有DNA探针2(与DNA探针1的碱基互补配对)的信号探针。当目的抗原存在时,检测探针经检测抗体和抗原,与芯片上捕获抗体结合固定在芯片上,信号探针通过碱基互补配对与检测探针结合使信号放大,最后利用纳米金成核原理染色,通过显微镜观察结果并定量分析。该体系在40 min内可检测多种标志物,其中肌钙蛋白Ⅰ( cTnⅠ)的检出限为10 pg/mL,与临床电化学发光法( ECLIA)灵敏度相当;肌红蛋白( MYO)与新型脂肪酸结合蛋白( HFABP)的检出限分别为640和10 pg/mL,与ECLIA及酶联免疫吸附法( ELISA)相比,灵敏度显著提高。
運用納米金複閤探針結閤蛋白芯片,建立瞭一種檢測心肌損傷標誌物的新方法。構建瞭2種納米金探針:標記有檢測抗體和DNA探針1的檢測探針和標記有DNA探針2(與DNA探針1的堿基互補配對)的信號探針。噹目的抗原存在時,檢測探針經檢測抗體和抗原,與芯片上捕穫抗體結閤固定在芯片上,信號探針通過堿基互補配對與檢測探針結閤使信號放大,最後利用納米金成覈原理染色,通過顯微鏡觀察結果併定量分析。該體繫在40 min內可檢測多種標誌物,其中肌鈣蛋白Ⅰ( cTnⅠ)的檢齣限為10 pg/mL,與臨床電化學髮光法( ECLIA)靈敏度相噹;肌紅蛋白( MYO)與新型脂肪痠結閤蛋白( HFABP)的檢齣限分彆為640和10 pg/mL,與ECLIA及酶聯免疫吸附法( ELISA)相比,靈敏度顯著提高。
운용납미금복합탐침결합단백심편,건립료일충검측심기손상표지물적신방법。구건료2충납미금탐침:표기유검측항체화DNA탐침1적검측탐침화표기유DNA탐침2(여DNA탐침1적감기호보배대)적신호탐침。당목적항원존재시,검측탐침경검측항체화항원,여심편상포획항체결합고정재심편상,신호탐침통과감기호보배대여검측탐침결합사신호방대,최후이용납미금성핵원리염색,통과현미경관찰결과병정량분석。해체계재40 min내가검측다충표지물,기중기개단백Ⅰ( cTnⅠ)적검출한위10 pg/mL,여림상전화학발광법( ECLIA)령민도상당;기홍단백( MYO)여신형지방산결합단백( HFABP)적검출한분별위640화10 pg/mL,여ECLIA급매련면역흡부법( ELISA)상비,령민도현저제고。
A novel method based on gold nanoparticles( AuNPs) probes and protein chip was developed to de-tect myocardial injury markers. Two AuNPs probes were constructed:one was modified with detection antibody and DNA probe 1(detection probe), and the other was labeled with DNA probe 2 which was complementary to DNA probe 1(signal probe). When target antigen was present, a sandwich structure(capture antibody-target antigen-detection probe-signal probe) was formed through the interaction of the antibody-antigen and the hy-bridization of complemenatry DNAs. Then the chip was dyed by the gold deposition solution, and the signal was amplified. The results were observed with a microscope linked with an image analysis software. This sys-tem could simultaneously detect multiple markers in 40 min. The detection limit of cTnⅠ was 10 pg/mL, which was equivalent to ECLIA in clinical. For HFABP and MYO, the detection limit could be as low as 640 and 10 pg/mL, respectively, and the sensitivity was improved greatly when compared with ECLIA and ELISA.